Видео ютуба по тегу Novo Nordisk

Join us in Novo Nordisk Manufacturing
Join us in Novo Nordisk Manufacturing
CEO DIALOGUE #35 - Lars Fruergaard Jørgensen, Novo Nordisk
CEO DIALOGUE #35 - Lars Fruergaard Jørgensen, Novo Nordisk
The spirit of our founders: The values and mindsets that created Novo Nordisk a century ago
The spirit of our founders: The values and mindsets that created Novo Nordisk a century ago
Novo Nordisk (Ozempic)
Novo Nordisk (Ozempic)
Novo Nordisk CEO Lars Fruergaard Jørgensen on Q4 results, Wegovy demand and drug pipeline outlook
Novo Nordisk CEO Lars Fruergaard Jørgensen on Q4 results, Wegovy demand and drug pipeline outlook
Novo Nordisk: Why the stock of the Danish pharmaceutical giant is plunging
Novo Nordisk: Why the stock of the Danish pharmaceutical giant is plunging
The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research
The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research
Novo Nordisk CEO says firm's obesity pill could launch before Eli Lilly
Novo Nordisk CEO says firm's obesity pill could launch before Eli Lilly
With Novo Nordisk success, is there a
With Novo Nordisk success, is there a "Nokia risk" for Denmark?
How a new Denmark tariff could impact Novo Nordisk
How a new Denmark tariff could impact Novo Nordisk
How Novo Nordisk built an empire selling diabetes and weight-loss drugs
How Novo Nordisk built an empire selling diabetes and weight-loss drugs
Novo Nordisk and Eli Lilly will dominate the obesity drug market long-term, says Mizuho's Jared Holz
Novo Nordisk and Eli Lilly will dominate the obesity drug market long-term, says Mizuho's Jared Holz
How Ozempic And Wegovy Accidentally Made Novo Nordisk A $400B Company
How Ozempic And Wegovy Accidentally Made Novo Nordisk A $400B Company
Novo Nordisk CEO expects same growth for 2025
Novo Nordisk CEO expects same growth for 2025
Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says
Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says
Novo Nordisk stock plunges on obesity shot trial results
Novo Nordisk stock plunges on obesity shot trial results
CagriSema still keeps the Novo Nordisk story in tact, says Barclays' Emily Field
CagriSema still keeps the Novo Nordisk story in tact, says Barclays' Emily Field
NBC News Exclusive: Ozempic and Wegovy Novo Nordisk CEO speaks out on high prices, drug shortages
NBC News Exclusive: Ozempic and Wegovy Novo Nordisk CEO speaks out on high prices, drug shortages
Novo Nordisk CEO defends high price off Ozempic and Wegovy
Novo Nordisk CEO defends high price off Ozempic and Wegovy